Sep 30, 2023

Arcturus Therapeutics Q3 2023 Earnings Report

Total Revenue
$45.1M
Previous year: $13.4M
+237.6%
EPS
-$0.61
Previous year: -$1.33
-54.1%
Gross Profit
$45.1M
Previous year: $13.4M
+237.6%
Cash and Equivalents
$347M
Previous year: $238M
+46.0%
Free Cash Flow
-$33.4M
Previous year: -$44.6M
-25.1%
Total Assets
$458M
Previous year: $294M
+55.9%

Arcturus Therapeutics

Arcturus Therapeutics